5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.80▼ | 0.80▼ | 0.81▼ | 0.81▲ | 0.72▲ |
MA10 | 0.81▼ | 0.81▼ | 0.79▲ | 0.77▲ | 0.77▲ |
MA20 | 0.77▲ | 0.76▲ | 0.76▲ | 0.72▲ | 0.89▼ |
MA50 | 0.77▲ | 0.75▲ | 0.72▲ | 0.77▲ | 1.13▼ |
MA100 | 0.78▲ | 0.70▲ | 0.73▲ | 0.91▼ | 1.17▼ |
MA200 | 0.72▲ | 0.84▼ | 0.88▼ | 1.05▼ | 3.31▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.000▼ | 0.002▲ | 0.002▲ | 0.019▲ | 0.001▲ |
RSI | 51.426▲ | 52.932▲ | 53.497▲ | 57.685▲ | 43.783▼ |
STOCH | 25.782 | 61.835 | 77.735 | 59.058 | 34.349 |
WILL %R | -73.684 | -31.818 | -31.818 | -45.570 | -50.794 |
CCI | -89.099 | 19.792 | 37.720 | 70.850 | -17.436 |
Thursday, April 24, 2025 04:48 PM
1 Day CNTB 13.75% DJIA 1.23% Russell 2K 2.00% Health Care/Life Sciences -0.64% ...
|
Thursday, April 24, 2025 06:12 AM
Connect Biopharma to present data on rademikibart for asthma and COPD at ATS 2025, initiating Phase 2 trials in 2025. Connect Biopharma Holdings Limited announced its plans to present four posters ...
|
Thursday, April 24, 2025 06:01 AM
SAN DIEGO, April 24, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma or the Company), a clinical-stage biopharmaceutical company focused on ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 0.8464 | 0.8464 | 0.80 | 0.82 | 39,612 |
30/04/25 | 0.8229 | 0.8464 | 0.75 | 0.8216 | 103,575 |
29/04/25 | 0.846 | 0.846 | 0.81 | 0.81 | 34,132 |
28/04/25 | 0.7928 | 0.8364 | 0.78 | 0.81 | 46,142 |
25/04/25 | 0.77 | 0.8097 | 0.7672 | 0.781 | 90,236 |
24/04/25 | 0.73 | 0.7767 | 0.685 | 0.7735 | 70,969 |
23/04/25 | 0.72 | 0.745 | 0.651 | 0.68 | 47,661 |
22/04/25 | 0.73 | 0.7559 | 0.65 | 0.6998 | 180,967 |
21/04/25 | 0.8039 | 0.8039 | 0.7072 | 0.745 | 96,010 |
17/04/25 | 0.85 | 0.88 | 0.7334 | 0.7392 | 103,779 |
|
|
||||
|
|
||||
|
|